Literature DB >> 21704687

Manganese in plasma: a promising biomarker of exposure to Mn in welders. A pilot study.

Perrine Hoet1, Els Vanmarcke, Tom Geens, Gladys Deumer, Vincent Haufroid, Harry A Roels.   

Abstract

BACKGROUND: There is raising concern about the potential neurotoxic effects of manganese (Mn) inhalation exposure in welders. Because most of the airborne particles in welding fume are in the respirable fraction, their bioavailability is likely to be higher than for coarser dust exposure. No well-validated biomarker for Mn exposure is available.
OBJECTIVES: To investigate the interest of measuring Mn in plasma (Mn-P) and urine (Mn-U) as biomarkers of exposure in a group of 28 welders whose tasks were only welding-related.
METHODS: Ambient air exposure to Mn (Mn-air) was determined by personal full-shift measurements on Monday and Tuesday. On the same days, blood and urine samples were collected before and after the shift.
RESULTS: Mn-air varied from 1.3 to 729 μg/m(3) (GM 27.7). For Mn-U 65% of the values in welders were below the LOQ (0.20 μg/L). Compared to controls, the welders' Mn-P averaged 33% higher (1.5 vs 2.0 μg/L). In welders, the after-shift Mn-P values correlated well with Mn-air above 10 μg/m(3). In spite of similar Mn-air exposure on Monday and Tuesday, the relationships between Mn-air and after-shift Mn-P strikingly differed on Tuesday in that the inflection in the relationship was less obvious and the slope of the regression line (Mn-P after-shift/logMn-air) for a doubling of logMn-air was 2.3 times lower than on Monday. On Monday (the first day of the workweek), a Mn-P value of 2 μg/L could distinguish Mn-air exposure above or below 20 μg/m(3) with a sensitivity of 69% and a specificity of 82%.
CONCLUSIONS: This preliminary study indicates that Mn-P is a promising biomarker of current exposure to Mn in welders and lends biological plausibility to the intended change for the Mn TLV-TWA of 20 μg/m(3) proposed by ACGIH for respirable Mn particulate.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21704687     DOI: 10.1016/j.toxlet.2011.06.013

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  6 in total

1.  Mechanisms of lead and manganese neurotoxicity.

Authors:  April P Neal; Tomas R Guilarte
Journal:  Toxicol Res (Camb)       Date:  2013-03-01       Impact factor: 3.524

2.  Toenail Manganese: A Sensitive and Specific Biomarker of Exposure to Manganese in Career Welders.

Authors:  Eric J Ward; David A Edmondson; Mahmoud M Nour; Sandy Snyder; Frank S Rosenthal; Ulrike Dydak
Journal:  Ann Work Expo Health       Date:  2017-12-15       Impact factor: 2.179

3.  Manganese exposure and cognitive deficits: a growing concern for manganese neurotoxicity.

Authors:  H A Roels; R M Bowler; Y Kim; B Claus Henn; D Mergler; P Hoet; V V Gocheva; D C Bellinger; R O Wright; M G Harris; Y Chang; M F Bouchard; H Riojas-Rodriguez; J A Menezes-Filho; Martha Maria Téllez-Rojo
Journal:  Neurotoxicology       Date:  2012-04-03       Impact factor: 4.294

4.  Manganese Intoxication Recovery and the Expression Changes of Park2/Parkin in Rats.

Authors:  Yu-Min Cao; Xi-Min Fan; Jie Xu; Jie Liu; Qi-Yuan Fan
Journal:  Neurochem Res       Date:  2021-11-28       Impact factor: 3.996

5.  Variance components of short-term biomarkers of manganese exposure in an inception cohort of welding trainees.

Authors:  Marissa G Baker; Christopher D Simpson; Lianne Sheppard; Bert Stover; Jackie Morton; John Cocker; Noah Seixas
Journal:  J Trace Elem Med Biol       Date:  2014-05-23       Impact factor: 3.849

6.  Determinants of serum manganese levels in an Italian population.

Authors:  Tommaso Filippini; Bernhard Michalke; Peter Grill; Carlotta Malagoli; Marcella Malavolti; Luciano Vescovi; Sabina Sieri; Vittorio Krogh; Andrea Cherubini; Giuseppe Maffeis; Roberto Lucchini; Margherita Ferrante; Marco Vinceti
Journal:  Mol Med Rep       Date:  2017-03-24       Impact factor: 3.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.